Investing
Payments to Acquire Other Investments
AbbVie Payments to Acquire Other Investments decreased by 20.4% to $266.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 8, 2026
How to read this metric
Higher payments indicate a focus on long-term strategic positioning or financial diversification.
Detailed definition
This represents cash outflows for the purchase of investments that do not fall under standard short-term marketable secu...
Peer comparison
Common for large-cap firms with diverse investment portfolios.
Metric ID:
investing_payments_to_acquire_other_investmentsHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $334.00M | $266.00M |
| QoQ Change | — | -20.4% |
| YoY Change | — | -20.4% |
Range$266.00M – $334.00M
Avg YoY Growth-20.4%
Median YoY Growth-20.4%
Payments to Acquire Other Investments at Other Companies
Frequently Asked Questions
- What is AbbVie's payments to acquire other investments?
- AbbVie (ABBV) reported payments to acquire other investments of $266.00M in Q1 2026.
- What does payments to acquire other investments mean?
- Cash spent on long-term or strategic investments outside of standard short-term securities.